Bayer AG
XETRA:BAYN
Bayer AG
Current Portion of Long-Term Debt
Bayer AG
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Current Portion of Long-Term Debt
€6.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Current Portion of Long-Term Debt
€625m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
4%
|
|
MPH Health Care AG
XETRA:93M1
|
Current Portion of Long-Term Debt
€17.4k
|
CAGR 3-Years
66%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Current Portion of Long-Term Debt
€116.4m
|
CAGR 3-Years
65%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Current Portion of Long-Term Debt
€8.1m
|
CAGR 3-Years
217%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
6.8B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Current Portion of Long-Term Debt amounts to 6.8B EUR.
What is Bayer AG's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
7%
Over the last year, the Current Portion of Long-Term Debt growth was -13%. The average annual Current Portion of Long-Term Debt growth rates for Bayer AG have been -7% over the past three years , 13% over the past five years , and 7% over the past ten years .